Study to Investigate the Efficacy of Symbicort® SMART.
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the efficacy of Symbicort SMART (Symbicort
Turbuhaler 160/4.5μg, one inhalation twice daily plus as needed) with Symbicort Turbuhaler
160/4.5μg, one inhalation twice daily plus terbutaline Turbuhaler 0.4 mg as needed, as asthma
therapy
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide, Formoterol Fumarate Drug Combination Terbutaline